Health-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000

doi:10.1016/S0149-2918(02)85012-3

Clinical Therapeutics

Volume 24, Issue 1, January 2002, Pages 142-169

https://doi.org/10.1016/S0149-2918(02)85012-3 Get rights and content

Abstract

Background: The goals of antihypertensive therapy are to achieve and maintain blood pressure control by the least intrusive means possible to prevent future cardiovascular and renal events. To achieve these goals, pharmacologic agents must be chosen so as to minimize drug-related adverse events, increase patient adherence to treatment regimens, and minimize the negative impact on health-related quality of life (HRQL). Although the effects of antihypertensive therapy on HRQL have been extensively investigated, there is little synthesis of the research findings.

Objective: This review was undertaken to provide a synthesis of the available data on the impact of antihypertensive therapy on HRQL and to provide recommendations for future research.

Methods: A MEDLINE literature search was conducted to identify English-language articles published from 1990 to 2000 that included random assignment to antihypertensive treatment and HRQL as an outcome. In addition, reference lists of published reviews and other trials were reviewed to identify other studies of HRQL and antihypertensive therapy.

Results: A total of 48 articles were included in the review. Results among studies were frequently inconsistent, which is likely due to the wide variety of dimensions studied and instruments used as well as a number of methodological weaknesses, including small sample sizes, short-term assessments, and failure to account for missing data.

Conclusion: A standardized approach to the assessment of HRQL in hypertensive patients is needed so that research in this area can be of value to clinical practice and to hypertensive patients and their families.

References (69)

NK Leidy et al.
Recommendations for evaluating the validity of quality of life claims for labeling and promotion
Value Health
(1999)
P Chan et al.
Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension
Am J Hypertens
(1997)
RH Grimm et al.
Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trial comparing doxazosin and hydrochlorothiazide
Am J Hypertens
(1996)
JB Kostis et al.
Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: A randomized, prospective trial
Am Heart J
(1992)
JH Levine et al.
Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension
Am J Hypertens
(1995)
E Paran et al.
The effects of replacing β-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients
Am J Hypertens
(1996)
MA Tedesco et al.
Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients
Am J Hypertens
(1999)
MR Weir et al.
Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy
Am J Hypertens
(1996)
A Muller et al.
Changes in physical symptoms, blood pressure and quality of life over 30 days
Behav Res Ther
(1994)
SK Gandhi et al.
Quality-of-life measures in the evaluation of antihypertensive drug therapy: Reliability, validity, and quality-of-life domains
Clin Ther
(1996)

American Heart Association. Available at: http://www.americanheart.org/statistics/hb. html. Accessed August 23,...

World Health Organization. Available at: http://www.who.int/whr/1997.exsum97e. htm. Accessed September 11,...

VL Burt et al.

Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991

Hypertension

(1995)

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Arch Intern Med

(1997)

SH Croog et al.

The effects of antihypertensive therapy on the quality of life

N Engl J Med

(1986)

P Hjemdahl et al.

Quality of life on antihypertensive drug therapy: Scientific end-point or marketing exercise?

J Hypertens

(1992)

JA Beto et al.

Quality of life in treatment of hypertension. A metaanalysis of clinical trials

Am J Hypertens

(1992)

SM Hunt

Quality of life claims in trials of anti-hypertensive therapy

Qual Life Res

(1997)

TM Gill et al.

A critical appraisal of the quality of quality-of-life measurements

JAMA

(1994)

BW Kong et al.

Quality of life as a vital clinical sign

J Hum Hypertens

(1990)

S Jern

Questionnaire for the Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy (the ASPECT scale)

Scand J Prim Health Care Suppl

(1990)

EH Ameling et al.

Impact of diagnosis and treatment of hypertension on quality of life: A double blind, randomized, placebo-controlled, cross-over study of betaxolol

J Cardiovasc Pharmacol

(1991)

RB Anderson et al.

Physical Symptoms Distress Index: A sensitive tool to evaluate the impact of pharmacological agents on quality of life

Arch Intern Med

(1999)

WB Applegate et al.

A randomized controlled trial of the effects of three antihypertensive agents on the blood pressure control and quality of life in older women

Arch Intern Med

(1991)

WB Applegate et al.

Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the systolic hypertension in the elderly program

Arch Intern Med

(1994)

JA Blumenthal et al.

Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril

Clin Pharmacol Ther

(1990)

JP Boissel et al.

A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: Field trial in general practice

J Hypertens

(1995)

JG Breed et al.

Quality of life perception during antihypertensive treatment: A comparative study of bisoprolol and enalapril

J Cardiovasc Pharmacol

(1992)

SW Chang et al.

The impact of diuretic therapy on reported sexual function

Arch Intern Med

(1991)

TJ Cleophas et al.

Quality of life before and during antihypertensive treatment: A comparative study of celiprolol and atenolol

Int J Clin Pharmacol Ther

(1996)

SH Croog et al.

Hypertensive black men and women. Quality of life and effects of antihypertensive medications

Arch Intern Med

(1990)

SH Croog et al.

Effects of antihypertensive medications on quality of life in elderly hypertensive women

Am J Hypertens

(1994)

C Dahlof et al.

Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well being

Eur J Clin Pharmacol

(1991)

B Dahlof et al.

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being

J Hypertens

(1997)

Cited by (25)

Health-Related Quality of Life in Hypertension, Chronic Kidney Disease, and Coexistent Chronic Health Conditions
2010, Advances in Chronic Kidney Disease
With the increasing prevalence of hypertension, there has been a growing interest in understanding the health-related quality of life (HRQOL) of patients with hypertension. Although hypertension is often perceived as asymptomatic, it is associated with impaired HRQOL because of complications or comorbidities, awareness of the diagnosis, and adverse effects from antihypertensive medications. This article focuses on the literature published since 2000, on HRQOL in elderly hypertensive individuals as well as hypertensives with co-existent diseases, including chronic kidney disease, cardiovascular disease, and diabetes mellitus. Most of the studies found that hypertensive individuals with co-existent co-morbidities tend to have lower HRQOL than those with hypertension alone, and identified the number of co-morbid illnesses as an independent determinant of HRQOL. The most pronounced effect was noted in the physical function domains of HRQOL. Studies have also examined the effects on HRQOL of specific classes of antihypertensive drugs without specific demonstration of superiority of one drug class over another in terms of HRQOL measures. Although there is evidence in favor of angiotensin-converting enzyme–inhibition for improving renal and cardiovascular outcomes in hypertensive patients, its role in ameliorating HRQOL outcomes remains to be established.
Antihypertensive drugs
2010, Side Effects of Drugs Annual
Citation Excerpt :
Active questioning can be undertaken verbally or by using questionnaires, whereas psychometric tests are designed to measure global well-being, without reference to any particular disorder (16r). It has, however, been difficult to assess quality of life reliably in patients with hypertension; a review of the literature from 1990 to 2000, focusing on health-related quality of life in patients with hypertension, showed that the results of studies were frequently inconsistent, possibly owing to the wide variety of domains studied, the variety of instruments used to assess quality of life, and a number of methodological weaknesses, including small sample sizes and failure to account for missing data (17R). It is important to note that although antihypertensive drug therapy can impair quality of life because of ADRs, hypertension itself may not be completely without effect.
This chapter discusses the effects of antihypertensive drugs. National surveys in the UK and USA have shown that a substantial number of patients with hypertension have poorly controlled blood pressures. Inadequate control of blood pressure can be attributed to both health-care provider-related and patient-related factors. A major patient-related factor is poor or non-adherence to prescribed medications. The chapter aim to elucidate the reasons for this non-adherence, including the effects of adverse effects from antihypertensive drugs and the effects of treatment on quality of life. The European Societies of Cardiology and Hypertension have produced guidelines on the management of arterial hypertension that reflect the most recent evidence base for using different classes of antihypertensive agents. The lower position of beta-adrenoceptor antagonists in the hierarchy of treatment in most recent guidelines not only reflects the evidence shift but also takes account of their undesirable effects in certain conditions. Further commentary on the place of beta-adrenoceptor antagonists in hypertension guidelines has reaffirmed concerns about their adverse metabolic effects and has emphasized their effects on erectile dysfunction.
Relationship between clinical and therapeutic variables and health-related quality of life in patients with hypertension. MINICHAL study
2003, Medicina Clinica
Evaluar, mediante el cuestionario de calidad de vida relacionada con lasalud (CVRS) MINICHAL, la influencia de las variables sociodemográficas, clínicas y terapéuticasen la calidad de vida relacionada con la salud de los pacientes hipertensos.
Estudio observacional, prospectivo y multicéntrico en pacientes hipertensosque iniciaban o modificaban tratamiento antihipertensivo. Se realizaron tres visitas, una basal ydos de seguimiento (una al mes y otra a los 6 meses). En ellas se registraron las variables sociodemográficas,clínicas y terapéuticas, y se aplicaron los cuestionarios validados de CVRS MINICHAL, la versión española del Índice de Bienestar Psicológico y una pregunta sobre el cambio en el estado de salud general con el objetivo de evaluar la influencia sobre la CVRS de dichas variables sociodemográficas, clínicas y terapéuticas.
Se evaluó a un total de 736 pacientes hipertensos. En el análisis multivariante, elsexo femenino, el número de enfermedades concomitantes, el grado de hipertensión arterial, elgrado de afección orgánica y el nivel educativo fueron las variables que se mostraron relacionadascon la CVRS. Se observó una mejoría de la CVRS tras 6 meses de intensificación del tratamiento,apreciándose una correlación positiva entre grado de reducción de presión arterial y de frecuenciacardíaca y mejora en la CVRS, especialmente en la dimensión de «Estado de ánimo».
En los pacientes hipertensos, el mejor control de la presión arterial incide favorablementesobre la CVRS. Además, ciertas características de los pacientes se correlacionan negativamentecon la CVRS, por lo que la intervención terapéutica debe estar especialmente dirigidaa corregir los factores modificables.
Our objective was to evaluate, through the health related quality oflife (HRQoL) questionnaire MINICHAL, the influence of socio-demographic, clinical and therapeuticvariables on health related quality of life of hypertensive patients.
An observational, prospective and multi-center study was carried out in hypertensivepatients who were either starting or undergoing a modification of antihypertensivetreatment. A total of three visits was done: a baseline visit and two follow-up visits at one andsix months. At all three visits, several socio-demographic, clinical and therapeutic variableswere recorded and HRQoL was measured using the MINICHAL questionnaire, the Spanish versionof the «Psychological General Well-Being Index», and a single question about the changein general health status. The objective was to evaluate the impact of these variables on HRQoL.
736 patients with hypertension were evaluated. In the multivariate analysis, gender,number of concomitant diseases, degree of hypertension, organ damage and educational levelwere all variables displaying a relation with HRQoL. After 6 months of treatment intensification,an improvement of HRQoL was observed. Moreover, a positive correlation was observedbetween the degree of reduction of blood pressure (BP) and heart rate and HRQoL improvement,especially in the «State of mind» dimension.
In hypertension, a better BP control has a positive influence on HRQoL. As severalclinical variables are negatively correlated with HRQoL, specific interventions are needed to correctmodifiable factors.
Validation of the short form of the Spanish Hypertension Quality of Life Questionnaire (MINICHAL)
2002, Clinical Therapeutics
Background: The finding that low health-related quality of life (HRQoL) can be a risk factor for future cardiovascular events in patients with hypertension emphasizes the need for disease-specific HRQoL assessment tools in this population.
Objective: This study evaluated the feasibility and psychometric properties of the short form of the Spanish Hypertension Quality of Life Questionnaire (MINICHAL).
Methods: An observational, prospective, multicenter study was carried out among patients with hypertension, stratified by sex and disease stage. The feasibility and validity of the MINICHAL were evaluated at baseline. Two follow-up visits were conducted at 1 and 6 months after the initial visit, during which the test-retest reliability and responsiveness to change of the MINICHAL were assessed, respectively.
Results: A total of 736 consecutive patients with hypertension were included. Mean (SD) administration time for the MINICHAL was 7.2 (6.5) minutes. In the validation process, factor analysis showed 2 dimensions: “State of mind” (StM) and “Somatic manifestations” (SM). The response level was high, with 94.3% of patients answering all items. Patients with a higher disease stage (ie, stage II/III hypertension) had a worse HRQoL than those with a lower disease stage (P < 0.01). Internal consistency was 0.87 for StM and 0.75 for SM. Test-retest reliability was 0.82 and 0.75 for the StM and SM dimensions, respectively. Among patients who reported experiencing a positive change in their overall health status 6 months after treatment initiation or treatment change, responsiveness to change ranged from 0.52 (better) to 1.14 (much better).
Conclusions: The MINICHAL questionnaire could be administered in a short time with a high response level and was found to have acceptable psychometric properties. The MINICHAL is a potentially useful tool for the evaluation of HRQoL among patients with hypertension in the routine clinical setting.
The relationship between antihypertensive medications and mood disorders: Analysis of linked healthcare data for 1.8 million patients
2021, Psychological Medicine
Does hypertension deteriorate the health-related quality of life (HRQoL)? A matched cross-sectional analytical study in an urban area of Puducherry, South India
2019, Heart India

View all citing articles on Scopus

View full text

Review articleHealth-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000

Abstract

Value Health

Am J Hypertens

Am J Hypertens

Am Heart J

Am J Hypertens

Am J Hypertens

Am J Hypertens

Am J Hypertens

Behav Res Ther

Clin Ther

Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991

Hypertension

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Arch Intern Med

The effects of antihypertensive therapy on the quality of life

N Engl J Med

Quality of life on antihypertensive drug therapy: Scientific end-point or marketing exercise?

J Hypertens

Quality of life in treatment of hypertension. A metaanalysis of clinical trials

Am J Hypertens

Quality of life claims in trials of anti-hypertensive therapy

Qual Life Res

A critical appraisal of the quality of quality-of-life measurements

JAMA

Quality of life as a vital clinical sign

J Hum Hypertens

Questionnaire for the Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy (the ASPECT scale)

Scand J Prim Health Care Suppl

Impact of diagnosis and treatment of hypertension on quality of life: A double blind, randomized, placebo-controlled, cross-over study of betaxolol

J Cardiovasc Pharmacol

Physical Symptoms Distress Index: A sensitive tool to evaluate the impact of pharmacological agents on quality of life

Arch Intern Med

A randomized controlled trial of the effects of three antihypertensive agents on the blood pressure control and quality of life in older women

Arch Intern Med

Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the systolic hypertension in the elderly program

Arch Intern Med

Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril

Clin Pharmacol Ther

A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: Field trial in general practice

J Hypertens

Quality of life perception during antihypertensive treatment: A comparative study of bisoprolol and enalapril

J Cardiovasc Pharmacol

The impact of diuretic therapy on reported sexual function

Arch Intern Med

Quality of life before and during antihypertensive treatment: A comparative study of celiprolol and atenolol

Int J Clin Pharmacol Ther

Hypertensive black men and women. Quality of life and effects of antihypertensive medications

Arch Intern Med

Effects of antihypertensive medications on quality of life in elderly hypertensive women

Am J Hypertens

Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well being

Eur J Clin Pharmacol

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being

J Hypertens

Review article
Health-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000